Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex for Emergence Agitation in Nasal Surgery
NCT07253428Active, not recruiting
- Sponsor
- Ain Shams University
- Start
- Oct 2025
- Primary completion
- Dec 2025
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in Emergence agitation (EA) (2 arms), sponsored by Ain Shams University. Primary endpoint: Incidence of Emergence Agitation. Started Oct 2025; status: active, not recruiting.
02
Drugs
Sugammadex
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07253428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07253428.